Hammock; Bruce D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hammock; Bruce D..The latest application filed is for "methods of treating mental disorders".

Company Profile

12.58.77

Hammock; Bruce D. - Davis CA
Hammock; Bruce D - Davis CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of improving cancer chemotherapy Grant 11,426,385 - Hammock , et al. August 30, 2	2022-08-30
Methods Of Treating Mental Disorders App 20220202744 - HAMMOCK; Bruce D. ; et al.	2022-06-30
NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif) App 20220169708 - HAMMOCK; Bruce D. ; et al.	2022-06-02
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif) Grant 11,225,514 - Hammock , et al. January 18, 2	2022-01-18
Orally Available Seh/pde4 Dual Inhibitors App 20210395202 - HAMMOCK; Bruce D. ; et al.	2021-12-23
Methods of treating mental disorders Grant 11,123,311 - Hammock , et al. September 21, 2	2021-09-21
Co-crystal Of Sorafenib Derivatives And Process For Preparation Thereof App 20210179549 - Hammock; Bruce D. ; et al.	2021-06-17
Methods Of Inhibiting Formation Of Alpha Synuclein Aggregates App 20210161881 - HAMMOCK; Bruce D. ; et al.	2021-06-03
Methods Of Improving Cell-based Therapy App 20210145891 - CHIAMVIMONVAT; Nipavan ; et al.	2021-05-20
Methods of inhibiting pain Grant 10,813,894 - Hammock , et al. October 27, 2	2020-10-27
Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase Grant 10,758,511 - Connor , et al. Sep	2020-09-01
NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif) App 20200231659 - HAMMOCK; Bruce D. ; et al.	2020-07-23
Methods Of Improving Cancer Chemotherapy App 20200197368 - HAMMOCK; Bruce D. ; et al.	2020-06-25
Treatment Of Inflammatory Disorders In Non-human Mammals App 20200000755 - Guedes; Alonso G. P. ; et al.	2020-01-02
Methods Of Improving Cell-based Therapy App 20190365733 - CHIAMVIMONVAT; Nipavan ; et al.	2019-12-05
Sorafenib derivatives as p21 inhibitors Grant 10,449,182 - Weiss , et al. Oc	2019-10-22
Treatment of inflammatory disorders in non-human mammals Grant 10,383,835 - Guedes , et al. A	2019-08-20
Potent soluble epdxide hydrolase inhibitors Grant 10,377,744 - Hammock , et al. A	2019-08-13
Methods of improving cell-based therapy Grant 10,369,141 - Chiamvimonvat , et al.	2019-08-06
Compounds and methods for inhibiting Cif virulence factor Grant 10,322,118 - Madden , et al.	2019-06-18
Methods Of Treating Mental Disorders App 20190125696 - HAMMOCK; Bruce D. ; et al.	2019-05-02
Stable Analogs of CYP450 Lipid Metabolites and Inhibitors of Soluble Epoxide Hydrolase App 20180325860 - Connor; Kip M. ; et al.	2018-11-15
Methods Of Improving Cell-based Therapy App 20180200244 - CHIAMVIMONVAT; Nipavan ; et al.	2018-07-19
Methods And Compositions For Treating Nephropathy App 20180185309 - HAMMOCK; Bruce D. ; et al.	2018-07-05
Methods Of Inhibiting Pain App 20180125803 - HAMMOCK; Bruce D. ; et al.	2018-05-10
Substituted piperidines as soluble epdxide hydrolase inhibitors Grant 9,850,207 - Hammock , et al. December 26, 2	2017-12-26
Potent Soluble Epoxide Hydrolase Inhibitors App 20170174665 - Hammock; Bruce D. ; et al.	2017-06-22
Compounds And Methods For Inhibiting Cif Virulence Factor App 20160206605 - Madden; Dean R. ; et al.	2016-07-21
Acyl Piperidine Inhibitors Of Soluble Epoxide Hydrolase App 20160200683 - Hammock; Bruce D. ; et al.	2016-07-14
Acyl piperidine inhibitors of soluble epoxide hydrolase Grant 9,296,693 - Hammock , et al. March 29, 2	2016-03-29
Methods Of Improving Cell-based Therapy App 20160008342 - CHIAMVIMONVAT; Nipavan ; et al.	2016-01-14
Use of sEH inhibitors as analgesics Grant 9,119,837 - Hammock , et al. September 1, 2	2015-09-01
Pyrazole inhibitors of COX-2 and sEH Grant 9,096,532 - Hammock , et al. August 4, 2	2015-08-04
Acyl piperidine inhibitors of soluble epoxide hydrolase Grant 9,034,903 - Hammock , et al. May 19, 2	2015-05-19
Sorafenib Derivatives As P21 Inhibitors App 20150132408 - Weiss; Robert H. ; et al.	2015-05-14
Sorafenib derivatives as sEH inhibitors Grant 9,029,401 - Hammock , et al. May 12, 2	2015-05-12
Conformationally restricted urea inhibitors of soluble epoxide hydrolase Grant 9,029,550 - Hammock , et al. May 12, 2	2015-05-12
Treating Neuropathic Pain with Seh Inhibitors App 20150065540 - Hammock; Bruce D. ; et al.	2015-03-05
Compounds And Methods For Inhibiting Cif Virulence Factor App 20150045389 - Madden; Dean R. ; et al.	2015-02-12
Treatment of Inflammatory Disorders in Non-Human Mammals App 20150017267 - Guedes; Alonso G.P. ; et al.	2015-01-15
Acyl Piperidine Inhibitors of Soluble Epoxide Hydrolase App 20150011586 - Hammock; Bruce D. ; et al.	2015-01-08
Inhibitors of epoxide hydrolases for the treatment of inflammation Grant 8,815,951 - Hammock , et al. August 26, 2	2014-08-26
Sorafenib Derivatives As Seh Inhibitors App 20140088156 - Hammock; Bruce D. ; et al.	2014-03-27
Pyrazole Inhibitors Of Cox-2 And Seh App 20140038923 - Hammock; Bruce D. ; et al.	2014-02-06
Conformationally Restricted Urea Inhibitors Of Soluble Epoxide Hydrolase App 20130274476 - Hammock; Bruce D. ; et al.	2013-10-17
Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids Grant 8,513,302 - Hammock , et al. August 20, 2	2013-08-20
Conformationally restricted urea inhibitors of soluble epoxide hydrolase Grant 8,501,783 - Hammock , et al. August 6, 2	2013-08-06
Inhibitors for the soluble epoxide hydrolase Grant 8,476,043 - Hammock , et al. July 2, 2	2013-07-02
Acyl Piperidine Inhibitors Of Soluble Epoxide Hydrolase App 20130143925 - Hammock; Bruce D. ; et al.	2013-06-06
Inhibitors for the soluble epoxide hydrolase Grant 8,455,652 - Hammock , et al. June 4, 2	2013-06-04
Conformationally Restricted Urea Inhibitors Of Soluble Epoxide Hydrolase App 20130137726 - Hammock; Bruce D. ; et al.	2013-05-30
Alleviating neuropathic pain with EETs and sEH inhibitors Grant 8,399,425 - Hammock , et al. March 19, 2	2013-03-19
Modulation Of Bioactive Epoxy-fatty Acid Levels By Phosphodiesterase Inhibitors App 20130065936 - Hammock; Bruce D. ; et al.	2013-03-14
USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS App 20130045172 - Hammock; Bruce D. ; et al.	2013-02-21
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors Grant 8,263,651 - Hammock , et al. September 11, 2	2012-09-11
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy Grant 8,242,170 - Chiamvimonvat , et al. August 14, 2	2012-08-14
Conformationally restricted urea inhibitors of soluble epoxide hydrolase Grant 8,188,289 - Hammock , et al. May 29, 2	2012-05-29
Inhibitors Of Soluble Epoxide Hydrolase To Inhibit Or Prevent Niacin-induced Flushing App 20120046251 - Schaefer; Saul ; et al.	2012-02-23
Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them Grant 8,119,404 - Huang , et al. February 21, 2	2012-02-21
Reducing Nephropathy With Inhibitors Of Soluble Epoxide Hydrolase And Epoxyeicosanoids App 20110269831 - Hammock; Bruce D. ; et al.	2011-11-03
Inhibitors Of Epoxide Hydrolases For The Treatment Of Hypertension App 20110245331 - Kroetz; Deanna L. ; et al.	2011-10-06
ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP App 20110230504 - Hammock; Bruce D. ; et al.	2011-09-22
Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors Grant 7,951,831 - Hammock , et al. May 31, 2	2011-05-31
Preparation Of Novel 1,3-substituted Ureas As Inhibitors Of Soluble Epoxide Hydrolase App 20110098322 - Sanborn; James R. ; et al.	2011-04-28
Methods And Compositions For Treatment Of Obesity-related Diseases App 20110065756 - De Taeye; Bart M. ; et al.	2011-03-17
Inhibitors for the Soluble Epoxide Hydrolase App 20110021448 - HAMMOCK; BRUCE D. ; et al.	2011-01-27
Use Of Cis-epoxyeicosantrienoic Acids And Inhibitors Of Soluble Epoxide Hydrolase To Reduce Pulmonary Infiltration By Neutrophils App 20100317733 - Hammock; Bruce D. ; et al.	2010-12-16
Use Of Inhibitors Of Soluble Epoxide Hydrolase To Synergize Activity Of Cox And 5-lox Inhibitors App 20100286222 - Hammock; Bruce D. ; et al.	2010-11-11
Inhibitor Of Apoptosis Proteins And Nucleic Acids And Methods For Making And Using Them App 20100275284 - Huang; Qihong ; et al.	2010-10-28
Alleviating Neuropathic Pain With Eets And Seh Inhibitors App 20100267807 - Hammock; Bruce D. ; et al.	2010-10-21
Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them Grant 7,786,347 - Huang , et al. August 31, 2	2010-08-31
Substituted Aminopyridines as Fluorescent Reporters for Amide Hydrolases App 20100160391 - Hammock; Bruce D. ; et al.	2010-06-24
Use Of Cis-epoxyeicosatrienoic Acids And Inhibitors Of Soluble Epoxide Hydrolase To Treat Conditions Mediated By Pbr, Cb2, And Nk2 Receptors App 20100074852 - Hammock; Bruce D. ; et al.	2010-03-25
Inhibitors for the soluble epoxide hydrolase Grant 7,662,910 - Hammock , et al. February 16, 2	2010-02-16
Inhibitors For The Soluble Epoxide Hydrolase App 20090326039 - Hammock; Bruce D. ; et al.	2009-12-31
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy App 20090216318 - Chiamvimonvat; Nipavan ; et al.	2009-08-27
Inhibition Of Phosphatase Activity Of Soluble Epoxide Hydrolase Amino Terminus And Uses Thereof App 20090215894 - Hammock; Bruce D. ; et al.	2009-08-27
Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids App 20090018092 - Hammock; Bruce D ; et al.	2009-01-15
Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders App 20080279912 - Hammock; Bruce D. ; et al.	2008-11-13
Use of Seh Inhibitors as Analgesics App 20080249055 - Hammock; Bruce D. ; et al.	2008-10-09
Methods Of Treating Avian Hypertension App 20080188554 - Hammock; Bruce D. ; et al.	2008-08-07
Conformationally Restricted Urea Inhibitors Of Soluble Epoxide Hydrolase App 20070225283 - Hammock; Bruce D. ; et al.	2007-09-27
Inhibitor Of Apoptosis Proteins And Nucleic Acids And Methods For Making And Using Them App 20070218507 - Huang; Qihong ; et al.	2007-09-20
Inhibitors Of Epoxide Hydrolases For The Treatment Of Inflammation App 20070117782 - Hammock; Bruce D. ; et al.	2007-05-24
Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use Grant 7,176,280 - Hammock , et al. February 13, 2	2007-02-13
Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them Grant 7,172,880 - Huang , et al. February 6, 2	2007-02-06
Inhibitors for the soluble epoxide hydrolase App 20060270609 - Hammock; Bruce D. ; et al.	2006-11-30
Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors App 20060178347 - Hammock; Bruce D. ; et al.	2006-08-10
Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke App 20060148744 - Hammock; Bruce D. ; et al.	2006-07-06
Inhibitors of epoxide hydrolases for the treatment of hypertension App 20060035869 - Hammock; Bruce D. ; et al.	2006-02-16
Inhibitors of epoxide hydrolases for the treatment of hypertension App 20050282767 - Kroetz, Deanna L. ; et al.	2005-12-22
Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils App 20050222252 - Hammock, Bruce D. ; et al.	2005-10-06
Inhibitors for the soluble epoxide hydrolase App 20050164951 - Hammock, Bruce D. ; et al.	2005-07-28
Inhibitors for the soluble epoxide hydrolase App 20050026844 - Hammock, Bruce D. ; et al.	2005-02-03
Inhibitors of epoxide hydrolases for the treatment of hypertension App 20040092487 - Kroetz, Deanna L. ; et al.	2004-05-13
Cyanohydrin ethers and esters as high-sensitivity enzyme substrates Grant 6,710,200 - Hammock , et al. March 23, 2	2004-03-23
Inhibitors of epoxide hydrolases for the treatment of hypertension Grant 6,693,130 - Kroetz , et al. February 17, 2	2004-02-17
Recombinant baculoviruses producing insect toxins Grant 6,689,356 - Zlotkin , et al. February 10, 2	2004-02-10
Cyanohydrin ethers and esters as high-sensitivity enzyme substrates App 20030207344 - Hammock, Bruce D. ; et al.	2003-11-06
Stabilized inorganic particles App 20030180780 - Feng, Jun ; et al.	2003-09-25
Use of inhibitors of soluble epoxide hydrolase to inhibit vascular smooth muscle cell proliferation App 20030139469 - Weiss, Robert H. ; et al.	2003-07-24
Inhibitors of epoxide hydrolases for the treatment of hypertension App 20030119900 - Kroetz, Deanna L. ; et al.	2003-06-26
Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use App 20030113892 - Hammock, Bruce D. ; et al.	2003-06-19
Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them App 20030049796 - Huang, Qihong ; et al.	2003-03-13
Inhibitors of epoxide hydrolases for the treatment of hypertension Grant 6,531,506 - Kroetz , et al. March 11, 2	2003-03-11
Cyanohydrin ethers and esters as high-sensitivity enzyme substrates Grant 6,528,675 - Hammock , et al. March 4, 2	2003-03-04
Diagnostic microarray apparatus Grant 6,395,562 - Hammock , et al. May 28, 2	2002-05-28
Insect control method with genetically engineered biopesticides App 20020037275 - Hammock, Bruce D. ; et al.	2002-03-28
Compact assay system with digital information Grant 6,342,395 - Hammock , et al. January 29, 2	2002-01-29
Epoxide hydrolase inhibitor methods Grant 6,174,695 - Hammock , et al. January 16, 2	2001-01-16
Epoxide hydrolase complexes and methods therewith Grant 6,150,415 - Hammock , et al. November 21, 2	2000-11-21
Dihydroxy-oxy-eicosadienoates Grant 5,955,496 - Hammock , et al. September 21, 1	1999-09-21
Insect control with multiple toxins Grant 5,756,340 - Hammock , et al. May 26, 1	1998-05-26
Enzyme amplified, complex linked, competitive and non-competitive assays for the detection of metal ions Grant 5,459,040 - Hammock , et al. October 17, 1	1995-10-17
Recombinant soluble epoxide hydrolase Grant 5,445,956 - Hammock , et al. August 29, 1	1995-08-29
Juvenile hormone esterase for insect control Grant 5,098,706 - Hammock , et al. March 24, 1	1992-03-24
Trifluoromethylketone sulfides and reversible enzyme inhibition therewith Grant 4,562,292 - Hammock , et al. December 31, 1	1985-12-31
Monitoring preneoplastic antigen Grant 4,558,004 - Hammock , et al. December 10, 1	1985-12-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.